NGS Sample Preparation Market Size is projected to reach USD 5.38 Billion by 2030, growing at a CAGR of 14.32%: Straits Research

The global NGS sample preparation market was valued at USD 1.41 billion in 2021 and is projected to reach USD 5.38 billion by 2030, registering a CAGR of 14.32% from 2022 to 2030. North America is the most important area for the NGS sample preparation market around the world.

Pune, INDIA


New York, United States, July 27, 2022 (GLOBE NEWSWIRE) -- The next-generation sequencing (NGS) industry is growing because of technologies that verify high-quality gene libraries and sequencing yields.

NGS changed how scientists study genes. NGS can take a day to sequence the human genome. The speed and flexibility of NGS are good for R&D. Sequencing advances are changing sample preparation techniques. Preparing the library and enriching the targets leads to correct sequencing and good data. Standard techniques for preparing samples have helped the NGS sample preparation industry grow because the field is always getting better. NGS is used to diagnose genetic diseases and treat them.


Get a Free Sample Copy of This Report @  https://straitsresearch.com/report/ngs-sample-preparation-market/request-sample


Alternative to PCR and Suitable for the Identification of Multiple Genes

Diagnostics should rise rapidly within the foreseeable timeframe. Each cancer patient's genome is sequenced utilising quicker and cheaper NGS-based genomic sequencing. NGS can currently be employed in clinical practice and research. ESMO has three levels of NGS guidelines for August 2020. ESMO endorses routine use of NGS on advanced non-squamous non-small-cell lung cancer (NSCLC), cholangiocarcinoma, and ovarian, and prostate cancer tissues. For colon malignancies, NGS can replace PCR. NGS can uncover several genes and mutations by sequencing millions of DNA reads, which can help with therapy.

Increase in the Genomic Research

Global genomic research programmes are also propelling the NGS sample preparation industry. Genomic research can help us understand biology, human history, and health variations, as well as clinical ramifications. Recent developments in sequencing technology allow for therapeutically meaningful genome and exome testing. NGS helps diagnose and monitor infectious disorders, which may boost the industry.

Risk of Discovering Unknown Variance

NGS makes mutations with unclear clinical relevance more likely. Large numbers of genes may lead to unwanted results, such as illness risk factors or unclassifiable variations. Experts like molecular pathologists and clinical geneticists are needed to determine how hazardous the variations are. NGS and genetically overlapping disorders raise important challenges in patient care and follow-up. "Genetic purgatory" is what Ackerman calls a "variant of unknown significance" (VUS).

Need for Many More Diagnostic Tools Due to The Increase in Cancer Globally

In its report "Globocan 2020," the International Agency for Research on Cancer (IARC) said that there would be 19.3 million new cancer cases and 10 million cancer deaths around the world in 2020. IARC says that 1 in 5 people will get cancer at some point in their lives, and 1 in 8 men and 1 in 11 women will die from the disease. Since the number of people with cancer is going up, there needs to be a lot more tools that can be used to make accurate diagnoses.


Report Scope

Report MetricDetails
Market SizeUSD 5.38 Billion by 2030
CAGR14.32%
Historical Data2019-2020
Base Year2021
Forecast Period2022-2030
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredProduct, Workflow, Technology, Application and End-User
Geographies CoveredNorth America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/VendorsThermo Fisher Scientific Inc., QIAGEN, Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Integrated DNA Technologies Inc., Illumina Inc, Tecan Trading AG., New England Biolabs
Key Market OpportunitiesNeed for many more diagnostic tools due to the increase in cancer globally
Key Market DriversAlternative to PCR and suitable for the identification of multiple genes
Increase in the genomic research

Buy Now Full Report @ https://straitsresearch.com/buy-now/ngs-sample-preparation-market


Regional Analysis of the Global NGS Sample Preparation Market

The market is split by region into North America, Europe, Asia-Pacific, and LAMEA.

In the global NGS sample preparation market, North America is where most of the money is made. The large share of this regional segment can be mostly attributed to government and private organisations' efforts to develop and use NGS technologies, the widespread use of NGS diagnostics in the region, the growing number of NGS-based research and clinical applications in the region, the growing research on cancer, the growing awareness of NGS services, and the presence of leading NGS service providers.


Key Highlights

  • The global NGS sample preparation market was valued at USD 1.41 billion in 2021 and is projected to reach USD 5.38 billion by 2030, registering a CAGR of 14.32% from 2022 to 2030.
  • The NGS sample preparation reagents and consumables segment are expected to grow at the highest rate during the forecast period
  • The diagnostics segment is expected to be the largest contributor to the NGS sample preparation market
  • North America contributed the most revenue and is expected to do the same


Get a Free Sample Copy of This Report @  https://straitsresearch.com/report/ngs-sample-preparation-market/request-sample


Competitive Players in the Global NGS Sample Preparation Market

  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Promega Corporation
  • Agilent Technologies
  • Integrated DNA Technologies, Inc.
  • Illumina, Inc.
  • Tecan Trading AG.
  • New England Biolabs


The Global NGS Sample Preparation Market Segmentation

By Product

  • Workstations
  • Reagents & Consumables

By Workflow

  • Library Preparation
  • DNA
    • Human Whole Genome Sequencing (WGS)
    • Targeted Sequencing
    • Whole Exome Sequencing (WES)
    • Others
  • RNA
    • Gene Expression Analysis
    • Whole Transcriptome Sequencing
    • Others
  • Target Enrichment
    • Targeted Seq
    • WES
    • Others
  • Quality Control

By Technology

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-molecule real-time (SMRT) Sequencing
  • Nanopore Sequencing
  • Other Technologies

By Application

  • Disease Diagnostics
    • Cancer Diagnostics
    • Reproductive Health Diagnostics
    • Infectious Disease Diagnostics
    • Other Disease Diagnostic Applications
  • Drug Discovery
  • Agricultural and Animal Research
  • Other Applications

By End-User

  • Academic Institutes and Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users (Includes non-profit organizations, agrigenomics organizations, reference laboratories, and consumer genomics companies, among others)

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of Asia Pacific
  • Rest of the world
    • South America
    • Middle East
    • Africa

TABLE OF CONTENT

  1. Introduction
    1. Market Definition
    2. Market Scope
  2. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  3. Market Overview
    1. Report Segmentation & Scope
    2. Value Chain Analysis: NGS Sample Preparation Market
    3. Key Market Trends
      1. Drivers
      2. Restraints
      3. Opportunities
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
    5. Market Share Analysis
  4. Product Overview
    1. Introduction
      1. Market Size & Forecast
    2. Workstations
      1. Market Size & Forecast
    3. Reagents & Consumables
      1. Market Size & Forecast
  5. Application Overview
    1. Introduction
      1. Market Size & Forecast
    2. Disease Diagnostics
      1. Market Size & Forecast
    3. Cancer Diagnostics
      1. Market Size & Forecast
  6. Regional Overview
    1. Introduction
      1. Market Size & Forecast
    2. America
      1. North America
      2. U.S.
        1. By Product
        2. By Application
      3. Canada
        1. By Product
        2. By Application
      4. Mexico
        1. By Product
        2. By Application
      5. Latin America
        1. By Product
        2. By Application
    3. Europe
      1. Market Size & Forecast
      2. Germany
        1. By Product
        2. By Application
      3. France
        1. By Product
        2. By Application
      4. U.K.
        1. By Product
        2. By Application
      5. Italy
        1. By Product
        2. By Application
      6. Spain
        1. By Product
        2. By Application
      7. Rest of Europe
        1. By Product
        2. By Application
    4. Asia Pacific
      1. Market Size & Forecast
      2. Japan
        1. By Product
        2. By Application
      3. China
        1. By Product
        2. By Application
      4. Australia
        1. By Product
        2. By Application
      5. India
        1. By Product
        2. By Application
      6. South Korea
        1. By Product
        2. By Application
      7. Rest of Asia-Pacific
        1. By Product
        2. By Application
    5. Middle East & Africa
      1. Market Size & Forecast
      2. Saudi Arabia
        1. By Product
        2. By Application
      3. South Africa
        1. By Product
        2. By Application
      4. Kuwait
        1. By Product
        2. By Application
      5. Rest of Middle East & Africa
        1. By Product
        2. By Application
  7. Company Profile
    1. Thermo Fisher Scientific Inc
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
    2. QIAGEN
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
    3. F Hoffmann-La Roche Ltd
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
  8. Conclusion & Recommendation
  9. Acronyms & Abbreviations


Table of Content and Figure @ https://straitsresearch.com/report/ngs-sample-preparation-market/toc


Recent Developments by Key Players

  • In December 2020, New England Biolabs launched the NEBNext Custom RNA depletion design tool and RNA depletion core reagent set for customizable RNA depletion
  • In June 2020, 10x Genomics, Inc. and Merck entered into a collaboration to provide impactful linking of two innovative technologies: single-cell transcriptomics and pooled CRISPR screening and researchers with more detailed information to better understand the relationship between specific genes and disease
  • In April 2020, Illumina made a software toolkit available free of charge to support the worldwide pandemic of COVID-19.
  • In February 2019, Agilent Technologies launched NGS library preparation systems which were designed to carry out complex DNA sequencing assays.
  • In 2018, Thermo Fisher Scientific introduced the Oncomine Childhood Cancer Research Assay which is a next-generation sequencing (NGS) model.

News Media
North America to Grab the Lion’s Share in the Clinical Laboratory Services Market
Rapidly Increasing Number of Clinical Trials to Boost the Growth of Clinical Trial Management System Market.
E-Clinical Software Solutions to Emerge as The Future of Clinical Trials


Have a Look at the Related Research Report               
Cell Culture Market: Information by Products (Consumables, Sera, Media, Reagents, Bioreactors), Application (Stem Cell Technology, Cancer Research), End-User, and Region — Forecast till 2030
Epigenetics Market: Information by Product (Instruments, Reagents & Kits), Application (Oncology, Autoimmune Diseases), and Region — Forecast till 2030
LDL Test Market: Information by Type (LDL-C, LDL-P, LDL-B), Component (Devices, Kits & Reagents), Application (Atherosclerosis, Obesity, Dyslipidemia), and Regional Outlook—Forecast Till 2026
Oligonucleotide Synthesis Market : Information by Type (Synthesized Oligonucleotide, Reagents, Equipment), Application (Research, Diagnostics, Therapeutics), End User—Forecast Till 2026


About Straits Research Pvt. Ltd.

StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

               

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)             

+44 208 068 9665 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter